EXEL Exelixis, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR पर देखें ↗ बंद अक्ट 2, 2026 10-K/10-Q अग 5, 2026
$58.39
· 52 सप्ताह की सीमा का %
· निम्न से ऊपर
· उच्च तक
$33.7652w निम्न
$61.1452w उच्च
मार्केट कैप (MRQ)
$14.53B
P/E (TTM)
15.4
EPS (TTM)
$3.79
राजस्व (TTM)
$2.56B
आपके बैज
52W रेंज
$34–$61
विश्लेषक रेटिंग
HOLD
मूल्य लक्ष्य
$54
P/E
15.4
ROE
52.5%
शुद्ध लाभ मार्जिन
39.8%
आपकी बैज स्ट्रिप खाली है — इस पेज पर कहीं भी एक मीट्रिक पिन करें।
EXEL स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$58.39
मार्केट कैप (MRQ)
$14.53B
P/E (TTM)
15.4
EPS (TTM)
$3.79
राजस्व (TTM)
$2.56B
ROE (TTM)
52.5%
52W रेंज
$34–$61
EXEL स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
सीमा
बार
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
Exelixis, Inc. - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
History
Exelixis was founded in 1994; the scientific founders were Spyridon Artavanis–Tsakonas, at Yale at that time, and Corey Goodman and Gerry Rubin who were then at the University of California, Berkeley. George Scangos joined the company as CEO in 1996. The business plan was to use model organisms (fruit flies, nematodes, and zebrafish) and functional genomics to identify pathways and biological targets that could be exploited in the fields of agriculture and medicine. It eventually set up a subsidiary, Exelixis Plant Sciences, for the agricultural work.
By 2000, Exelixis had left the radical exploratory phase behind and became focused on drug discovery and had a chemical library of 4 million compounds. The company went public that year, after withdrawing its offering the week before; it raised $118 million in a down market.
In 2002, the company signed a broad alliance with GSK to discover new drugs in the fields of cancer, inflammatory diseases, and vascular conditions; GSK paid it $30 million in cash, bought $14 million in stock at twice the market rate, and committed to providing Exelixis with $90 million in research funding; it also offered loan financing of up to $85 million. By 2002, the company had limited its internal efforts to cancer, and had settled its strategy on discovering and developing drugs that could inhibit targeted small sets of tyrosine kinases that are needed for cancer formation, growth, and metastasis. The sets of TKs had been identified by means of its prior functional genomics work. This approach was controversial at the time; most companies try to selectively target just one protein in their discovery efforts.
In 2006, Exelixis partnered with Daiichi Sankyo on compounds that targeted mineralocorticoid receptors; esaxerenone was part of this collaboration. In 2007, the company partnered its MEK inhibitor program with Genentech; cobimetinib (at that time XL-518) was part of this collaboration. Exelixis had filed an IND on XL-518 prior to the partnership, committed to funding and running the Phase I trial, and retained rights to co-market it in the US.
In 2008, the company partnered its lead cancer drug candidate, XL-184 (which would become called cabozantinib) and another cancer candidate, XL-281, with Bristol Myers Squibb; BMS returned the rights to XL-184 to Exelixis in 2010 and returned the rights to other drug candidate in 2011.
In 2010, Scangos departed as CEO to take over at Biogen and the company appointed Michael M. Morrissey as president and CEO; Morrissey had joined the company in 2000 as Vice President of Discovery Research. At that time the company had eight drugs in clinical trials. Exelixis' first drug approval came in 2012, when cabozantinib was approved for medullary thyroid cancer, an orphan indication. It was approved in Europe in 2014. Exelixis invested heavily in exploring cabozantinib in other cancers, betting the future of the company on the drug. In 2014 the drug failed a Phase III trial in prostate cancer, and the company laid off 70% of its employees. In 2015, Genentech and Exelixis won FDA approval for cobimetinib for certain forms of melanoma.
In March 2016, Exelixis licensed to Ipsen worldwide rights (outside the US, Canada, and Japan) to market cabozantinib. In April 2016, the FDA granted approval for marketing the tablet formulation as a second line treatment for kidney cancer and the same was approved in Europe in October of that year.
In December 2017, the FDA granted approval for the use of cabozantinib for first line treatment of kidney cancer and in 2018 approval for first-line treatment was approved in Europe.
Finance
Pricing
Cabometyx (cabozantinib)
In 2023, the Institute for Clinical and Economic Review (ICER) identified Cabometyx (cabozantinib) as one of five high-expenditure drugs that experienced significant net price increases without new clinical evidence to justify the hikes. Specifically, Cabometyx's wholesale acquisition cost rose by 7.5%, leading to an additional $86 million in costs to U.S. payers.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
क्षेत्रHealthcare
उद्योगBiotechnology
कर्मचारी1077
देशUS
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व$2.32B2016-12-31 → 2026-01-02
EPS$2.782017-12-29 → 2026-01-02
फ्री कैश फ्लो$876M2017-12-29 → 2026-01-02
शुद्ध मार्जिन39.8%2017-12-29 → 2026-01-02
मूल्यांकन और अनुपात
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | EXEL | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E (TTM) | 15.45Y औसत ≈25.2 | ≈25.2 | 21.1 | अल्पमूल्यित | |
| P/S (TTM) | 5.75Y औसत ≈4.1 | ≈4.1 | 5.4 | उचित मूल्य | |
| P/B (MRQ) | 7.95Y औसत ≈3.5 | ≈3.5 | 7.5 | उचित मूल्य | |
| मूल्य / FCF (TTM) | 11.35Y औसत ≈17.0 | ≈17.0 | · | · | |
| मूल्य / नकदी प्रवाह (TTM) | 11.45Y औसत ≈15.5 | ≈15.5 | 13.3 | उचित मूल्य | |
| Price / Tangible Book (मूल्य / मूर्त पुस्तक) | 7.15Y औसत ≈3.6 | ≈3.6 | · | · | |
| PEG Ratio (PEG अनुपात) | ≈0.3 | · | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | EXEL | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| परिचालन मार्जिन (TTM) | 45.7%5Y औसत ≈21.5% | ≈21.5% | 27.7% | शीर्ष स्तर | |
| EBITDA मार्जिन (TTM) | 46.8%5Y औसत ≈22.7% | ≈22.7% | 15.8% | शीर्ष स्तर | |
| शुद्ध लाभ मार्जिन (TTM) | 39.8%5Y औसत ≈19.3% | ≈19.3% | 15.1% | शीर्ष स्तर | |
| ROA (TTM) | 39.3%5Y औसत ≈13.6% | ≈13.6% | 8.0% | शीर्ष स्तर | |
| ROE (TTM) | 52.5%5Y औसत ≈17.5% | ≈17.5% | 17.4% | शीर्ष स्तर |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | EXEL | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| वर्तमान अनुपात (MRQ) | 3.55Y औसत ≈4.2 | ≈4.2 | 3.3 | अनुरूप | |
| त्वरित अनुपात (MRQ) | 3.25Y औसत ≈3.9 | ≈3.9 | 2.4 | मजबूत तरलता |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | EXEL | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | 7.0%5Y औसत ≈19.3% | ≈19.3% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | 12.9%5Y औसत ≈16.8% | ≈16.8% | · | · | |
| Revenue CAGR 5Y (राजस्व CAGR 5Y) | 18.6% | · | · | · | |
| EPS YoY | 58.0%5Y औसत ≈65.7% | ≈65.7% | · | · | |
| Net Income YoY (शुद्ध आय YoY) | 50.1%5Y औसत ≈60.1% | ≈60.1% | · | · | |
| EPS CAGR 3Y | 70.6%5Y औसत ≈42.7% | ≈42.7% | · | · | |
| EPS CAGR 5Y | 51.3% | · | · | · | |
| Net Income CAGR 3Y (शुद्ध आय CAGR 3Y) | 62.5%5Y औसत ≈38.9% | ≈38.9% | · | · | |
| Net Income CAGR 5Y (शुद्ध आय CAGR 5Y) | 47.6% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | EXEL | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Asset Turnover (परिसंपत्ति टर्नओवर) | 0.85Y औसत ≈0.7 | ≈0.7 | 0.6 | शीर्ष स्तर | |
| Inventory Turnover (इन्वेंटरी टर्नओवर) | 3.85Y औसत ≈2.9 | ≈2.9 | 1.4 | शीर्ष स्तर | |
| Receivables Turnover (प्राप्य टर्नओवर) | 8.45Y औसत ≈7.6 | ≈7.6 | 7.0 | शीर्ष स्तर | |
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$2.2M | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
15.3%
अगली रिपोर्ट
नव 02, 2026
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 30 जून 2026 | जुल 27, 2026 | $0.82 | $0.80 | 2.3% |
| 31 मार्च 2026 | मई 11, 2026 | $0.79 | $0.72 | 10.1% |
| 31 दिसमबर 2025 | $0.88 | $0.82 | 7.0% | |
| 30 सितमबर 2025 | $0.69 | $0.63 | 9.3% | |
| 30 जून 2025 | $0.65 | $0.57 | 14.0% | |
| 31 मार्च 2025 | $0.55 | $0.37 | 49.0% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.32B | $2.17B | $1.83B | $1.61B | $1.43B | $988M | $968M | $854M | $452M | $191M | $37M | |
| Cost of Revenue | $84M | $76M | $73M | $58M | $53M | $36M | $33M | $26M | $15M | $7M | $4M | |
| R&D Expense | $825M | $910M | $1.04B | $892M | $694M | $548M | $337M | $182M | $112M | $96M | $96M | |
| SG&A Expense | $519M | $492M | $543M | $460M | $402M | $293M | $228M | $206M | $159M | $116M | $57M | |
| Operating Expenses | $1.45B | $1.56B | $1.66B | $1.41B | $1.15B | $877M | $598M | $415M | $287M | $220M | $159M | |
| Operating Income | $872M | $605M | $171M | $201M | $287M | $110M | $369M | $439M | $166M | $-28M | $-121M | |
| Interest Expense | · | · | · | · | · | · | $0 | $0 | $9M | $33M | $41M | |
| Other Non-op | $-198.0K | $-133.0K | $93.0K | $-197.0K | $-184.0K | $912.0K | $680.0K | $397.0K | $-4M | $5M | $-381.0K | |
| Pretax Income | · | · | · | · | · | $131M | $398M | $452M | $159M | $-70M | $-162M | |
| Income Tax | $159M | $160M | $50M | $52M | $63M | $19M | $77M | $-238M | $4M | $0 | $55.0K | |
| Net Income | $783M | $521M | $208M | $182M | $231M | $112M | $321M | $690M | $154M | $-70M | $-162M | |
| EPS (Basic) | $2.88 | $1.80 | $0.65 | $0.57 | $0.73 | $0.36 | $1.06 | $2.32 | $0.52 | · | $-0.77 | |
| EPS (Diluted) | $2.78 | $1.76 | $0.65 | $0.56 | $0.72 | $0.35 | $1.02 | $2.21 | $0.49 | · | $-0.77 | |
| Shares (Basic) | 271,567,000 | 290,030,000 | 318,151,000 | 321,526,000 | 314,884,000 | 308,271,000 | 302,584,000 | 297,892,000 | 293,588,000 | · | 209,227,000 | |
| Shares (Diluted) | 281,863,000 | 296,132,000 | 321,464,000 | 324,556,000 | 322,359,000 | 318,001,000 | 315,009,000 | 312,803,000 | 312,003,000 | · | 209,227,000 | |
| EBITDA | $901M | $633M | $197M | $222M | $300M | $119M | $378M | $444M | $167M | · | · |
बैलेंस शीट
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $482M | $217M | $263M | $501M | $647M | $319M | $267M | $315M | $183M | $152M | $142M | |
| Short-term Investments | $577M | $894M | $732M | $807M | $820M | $887M | $586M | $379M | $205M | $268M | · | |
| Receivables | $287M | $265M | $237M | $215M | $283M | $161M | $119M | $163M | $77M | $40M | · | |
| Inventory | $22M | $22M | $17M | $33M | $27M | $21M | $13M | $10M | $7M | $3M | · | |
| Prepaid Expense | $76M | $68M | $68M | $62M | $58M | $57M | $27M | $31M | $9M | $5M | · | |
| Current Assets | $1.44B | $1.47B | $1.32B | $1.62B | $1.83B | $1.45B | $1.01B | $897M | $485M | $469M | · | |
| PP&E (Net) | $99M | $119M | $129M | $111M | $104M | $67M | $49M | $51M | $26M | $2M | · | |
| PP&E (Gross) | $231M | $220M | $209M | $171M | $145M | $102M | $74M | $68M | $49M | $27M | · | |
| Accum. Depreciation | $132M | $101M | $80M | $61M | $41M | $35M | $26M | $17M | $23M | $25M | · | |
| Goodwill | $64M | $64M | $64M | $64M | $64M | $64M | $64M | $64M | $64M | $64M | · | |
| Other Non-current Assets | · | · | · | · | $131M | $73M | $53M | $8M | $12M | $1M | · | |
| Total Assets | $2.84B | $2.95B | $2.94B | $3.07B | $2.62B | $2.14B | $1.89B | $1.42B | $655M | $596M | · | |
| Accounts Payable | $30M | $38M | $34M | $33M | $24M | $24M | $12M | $11M | $10M | $7M | · | |
| Short-term Debt | · | · | · | · | · | · | · | · | $0 | $80M | · | |
| Current Liabilities | $406M | $404M | $394M | $324M | $338M | $205M | $143M | $105M | $115M | $269M | · | |
| Capital Leases | $173M | $191M | $190M | $190M | $51M | $49M | $48M | $12M | $15M | · | · | |
| Other Non-current Liabilities | $104M | $109M | $94M | $69M | $8M | $721.0K | $2M | $1M | $2M | $541.0K | · | |
| Total Liabilities | $683M | $703M | $678M | $583M | $406M | $258M | $200M | $135M | $370M | $506M | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | $0 | $189M | · | |
| Total Debt | · | · | · | · | · | · | · | · | $0 | · | · | |
| Common Stock | $262.0K | $282.0K | $303.0K | $324.0K | $319.0K | $312.0K | $305.0K | $300.0K | $296.0K | $290.0K | · | |
| Paid-in Capital | $2.23B | $2.34B | $2.44B | $2.54B | $2.43B | $2.32B | $2.24B | $2.17B | $2.11B | $2.07B | · | |
| Retained Earnings | $-77M | $-99M | $-173M | $-34M | $-217M | $-448M | $-559M | $-880M | $-1.83B | $-1.98B | · | |
| AOCI | $3M | $-1M | $-4M | $-15M | $-758.0K | $4M | $3M | $-701.0K | $-347.0K | $-416.0K | · | |
| Stockholders' Equity | $2.16B | $2.24B | $2.26B | $2.49B | $2.21B | $1.88B | $1.69B | $1.29B | $285M | $89M | $-141M | |
| Liabilities + Equity | $2.84B | $2.95B | $2.94B | $3.07B | $2.62B | $2.14B | $1.89B | $1.42B | $655M | $596M | · | |
| Shares Outstanding | 262,483,000 | 281,732,000 | 302,793,000 | 323,951,000 | 318,842,000 | 311,627,000 | 304,831,000 | 299,876,000 | 296,209,000 | 289,923,798 | 227,960,943 |
नकदी प्रवाह
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $29M | $29M | $26M | $21M | $14M | $9M | $8M | $5M | $1M | $1M | $1M | |
| Stock-based Comp | $113M | $94M | $106M | $108M | $120M | $105M | $57M | $41M | $24M | $23M | $22M | |
| Deferred Tax | $126M | $-59M | $-133M | $-60M | $47M | $15M | $71M | $-244M | $0 | $0 | $0 | |
| Restructuring | $21M | $34M | $0 | $0 | · | · | · | $0 | $-32.0K | $63M | $1M | |
| Other Non-cash | $-167M | $116M | $127M | $112M | $-10M | $-32M | $70M | $-76M | $-14M | · | · | |
| Operating Cash Flow | $884M | $700M | $333M | $363M | $401M | $209M | $527M | $416M | $166M | $206M | $-141M | |
| CapEx | $8M | $28M | $40M | $28M | $54M | $30M | $13M | $33M | $21M | $2M | $447.0K | |
| Investing Cash Flow | $350M | $-117M | $-27M | $-524M | $-43M | $-131M | $-587M | $-298M | $37M | $-216M | $50M | |
| Net Debt Issued | · | · | · | · | · | · | $0 | $0 | $-186M | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | $146M | |
| Stock Repurchased | $948M | $652M | $550M | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $-948M | $-652M | $-550M | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-970M | $-629M | $-546M | $586.0K | $-15M | $-25M | $13M | $10M | $-170M | $20M | $152M | |
| Net Change in Cash | $265M | $-46M | $-240M | $-161M | $343M | $53M | $-48M | $128M | $32M | $10M | $61M | |
| Taxes Paid | $155M | $170M | $186M | $128M | $13M | $4M | $8M | $11M | $538.0K | · | · | |
| Free Cash Flow | $876M | $672M | $293M | $335M | $337M | $179M | $514M | $382M | $144M | · | · | |
| Levered FCF | · | · | · | · | · | · | $514M | $382M | $136M | · | · |
लाभप्रदता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 37.6% | 27.9% | 9.3% | 12.5% | 20.0% | 11.1% | 38.2% | 51.4% | 36.7% | · | · | |
| Net Margin | 33.7% | 24.0% | 11.3% | 11.3% | 16.1% | 11.3% | 33.2% | 80.8% | 34.1% | · | · | |
| Pretax Margin | · | · | · | · | · | 13.2% | 41.1% | 52.9% | 35.0% | · | · | |
| EBITDA Margin | 38.8% | 29.2% | 10.7% | 13.8% | 20.9% | 12.1% | 39.0% | 52.0% | 36.9% | · | · | |
| ROA | 27.0% | 17.7% | 6.9% | 6.4% | 9.7% | 5.6% | 19.4% | 66.4% | 24.7% | · | · | |
| ROE | 37.3% | 23.1% | 9.0% | 7.3% | 10.7% | 6.0% | 19.5% | 62.6% | 82.4% | · | · | |
| ROIC | · | · | · | · | · | 5.0% | 17.7% | 52.0% | 56.6% | · | · |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 3.6 | 3.3 | 5.0 | 5.4 | 7.1 | 7.1 | 8.5 | 4.2 | · | · | |
| Quick Ratio | 3.3 | 3.4 | 3.1 | 4.7 | 5.2 | 6.7 | 6.8 | 8.1 | 4.1 | · | · | |
| Debt / Equity | · | · | · | · | · | · | · | · | 0.0 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | 19.1 | · | · |
दक्षता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.8 | 0.7 | · | · | |
| Inventory Turnover | 3.8 | 3.8 | 2.9 | 1.9 | 2.2 | 2.1 | 2.9 | 3.2 | 3.0 | · | · | |
| Receivables Turnover | 8.4 | 8.6 | 8.1 | 6.5 | 6.5 | 7.1 | 6.9 | 9.8 | 7.4 | · | · |
प्रति शेयर
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.23 | $7.97 | $7.48 | $7.68 | $6.93 | $6.03 | $5.53 | $4.29 | $0.96 | · | · | |
| Revenue / Share | $8.23 | $7.32 | $5.69 | $4.96 | $4.45 | $3.11 | $3.07 | $2.73 | $1.45 | · | · | |
| Cash Flow / Share | $3.14 | $2.36 | $1.04 | $1.12 | $1.24 | $0.66 | $1.67 | $1.33 | $0.53 | · | · | |
| Cash / Share | $1.84 | $0.77 | $0.87 | $1.55 | $2.03 | $1.02 | $0.87 | $1.05 | $0.62 | · | · | |
| EPS (TTM) | $2.78 | $1.76 | $0.65 | $0.56 | $0.72 | $0.35 | $1.02 | $2.21 | $0.49 | · | $-0.77 |
विकास दरें
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.0% | 18.5% | 13.6% | 12.3% | 45.3% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.9% | 14.8% | 22.8% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.6% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 58.0% | 170.8% | 16.1% | -22.2% | 105.7% | · | · | · | · | · | · | |
| EPS CAGR 3Y | 70.6% | 34.7% | 22.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 51.3% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 50.1% | 150.9% | 14.0% | -21.1% | 106.7% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 62.5% | 31.1% | 22.9% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 47.6% | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.32B | $2.17B | $1.83B | $1.61B | $1.43B | $988M | $968M | $854M | $452M | · | $37M | |
| Net Income TTM | $783M | $521M | $208M | $182M | $231M | $112M | $321M | $690M | $154M | · | $-162M | |
| Market Cap | $11.44B | $9.57B | $7.26B | $5.20B | $5.83B | $6.25B | $5.19B | $5.83B | $9.00B | · | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | $8.62B | · | · | |
| P/E | 15.7 | 19.3 | 36.9 | 28.6 | 25.4 | 57.3 | 16.7 | 8.8 | 62.0 | · | -7.3 | |
| P/S | 4.9 | 4.4 | 4.0 | 3.2 | 4.1 | 6.3 | 5.4 | 6.8 | 19.9 | · | · | |
| P/B | 5.3 | 4.3 | 3.2 | 2.1 | 2.6 | 3.3 | 3.1 | 4.5 | 31.6 | · | · | |
| P / Tangible Book | 5.5 | 4.4 | 3.3 | 2.1 | 2.7 | 3.4 | · | · | · | · | · | |
| P / Cash Flow | 12.9 | 13.7 | 21.8 | 14.3 | 14.5 | 29.9 | 9.8 | 14.0 | 54.4 | · | · | |
| P / FCF | 13.1 | 14.3 | 24.8 | 15.5 | 17.3 | 35.0 | 10.1 | 15.2 | 62.3 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | 51.6 | · | · | |
| EV / FCF | · | · | · | · | · | · | · | · | 59.6 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | 19.0 | · | · | |
| Earnings Yield | 6.4% | 5.2% | 2.7% | 3.5% | 3.9% | 1.7% | 6.0% | 11.4% | 1.6% | · | -13.7% |
आय विवरण
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2024 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $629M | $611M | $718M | $598M | $568M | $555M | $818M | $540M | $637M | $425M | $480M | $472M | $470M | $409M | $424M | $412M | |
| Cost of Revenue | $21M | $20M | $27M | $19M | $19M | $19M | $25M | $17M | $18M | $21M | $22M | $19M | $18M | $14M | $16M | $15M | |
| R&D Expense | $212M | $200M | $164M | $199M | $200M | $212M | $111M | $223M | $211M | $228M | $245M | $333M | $233M | $234M | $337M | $199M | |
| SG&A Expense | $148M | $140M | $161M | $124M | $135M | $137M | $81M | $112M | $132M | $114M | $131M | $138M | $142M | $131M | $119M | $115M | |
| Operating Expenses | $380M | $359M | $287M | $361M | $355M | $369M | $303M | $403M | $361M | $396M | $398M | $490M | $392M | $380M | $472M | $329M | |
| Operating Income | $248M | $251M | $431M | $237M | $214M | $187M | $516M | $136M | $276M | $29M | $82M | $-18M | $78M | $29M | $-48M | $83M | |
| Other Non-op | $54.0K | $219.0K | $207.0K | $-49.0K | $50.0K | $-245.0K | $-363.0K | $-29.0K | $-287.0K | $-89.0K | $-137.0K | $289.0K | $-5.0K | $-54.0K | $-337.0K | $-69.0K | |
| Income Tax | $51M | $57M | $43M | $59M | $46M | $46M | $128M | $37M | $67M | $12M | $18M | $5M | $19M | $8M | $-1M | $19M | |
| Net Income | $212M | $210M | $401M | $194M | $185M | $160M | $399M | $118M | $226M | $37M | $86M | $1M | $81M | $40M | $-30M | $73M | |
| EPS (Basic) | $0.85 | $0.81 | $1.57 | $0.72 | $0.68 | $0.57 | $1.43 | $0.41 | $0.78 | $0.12 | $0.28 | $0.00 | $0.25 | $0.12 | $-0.09 | $0.23 | |
| EPS (Diluted) | $0.82 | $0.79 | $1.49 | $0.69 | $0.65 | $0.55 | $1.39 | $0.40 | $0.77 | $0.12 | $0.28 | $0.00 | $0.25 | $0.12 | $-0.09 | $0.23 | |
| Shares (Basic) | 250,808,000 | 258,329,000 | · | 268,421,000 | 272,583,000 | 278,804,000 | · | 285,622,000 | 289,216,000 | 300,757,000 | · | 315,496,000 | 324,205,000 | 324,420,000 | · | 322,148,000 | |
| Shares (Diluted) | 259,675,000 | 267,322,000 | · | 278,535,000 | 284,393,000 | 288,177,000 | · | 291,478,000 | 293,974,000 | 305,530,000 | · | 319,247,000 | 327,305,000 | 326,279,000 | · | 325,066,000 | |
| EBITDA | $248M | $258M | · | $237M | $214M | $194M | · | $136M | $276M | $36M | · | $-18M | $78M | $36M | · | $83M |
बैलेंस शीट
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2024 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $281M | $226M | $482M | $376M | $164M | $184M | $217M | $258M | $198M | $260M | · | $397M | $464M | $541M | · | $675M | |
| Short-term Investments | $558M | $551M | $577M | $612M | $627M | $848M | $894M | $931M | $804M | $704M | · | $707M | $802M | $773M | · | $872M | |
| Receivables | $322M | $329M | $287M | $310M | $292M | $282M | $265M | $270M | $397M | $241M | · | $248M | $233M | $234M | · | $215M | |
| Inventory | $29M | $27M | $22M | $27M | $23M | $25M | $22M | $21M | $21M | $21M | · | $25M | $29M | $30M | · | $27M | |
| Prepaid Expense | $60M | $76M | $76M | $77M | $74M | $59M | $68M | $70M | $58M | $67M | · | $67M | $62M | $61M | · | $53M | |
| Current Assets | $1.25B | $1.21B | $1.44B | $1.40B | $1.18B | $1.40B | $1.47B | $1.55B | $1.48B | $1.29B | · | $1.44B | $1.59B | $1.64B | · | $1.84B | |
| PP&E (Net) | $93M | $96M | $99M | $105M | $110M | $115M | $119M | $124M | $130M | $127M | · | $121M | $115M | $116M | · | $108M | |
| PP&E (Gross) | · | · | $231M | · | · | · | $220M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $132M | · | · | · | $101M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $64M | $64M | $64M | $64M | $64M | $64M | $64M | $64M | $64M | $64M | · | $64M | $64M | $64M | · | $64M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $280M | |
| Total Assets | $2.49B | $2.59B | $2.84B | $2.82B | $2.68B | $2.84B | $2.95B | $2.96B | $2.77B | $2.80B | · | $2.98B | $3.14B | $3.14B | · | $2.96B | |
| Accounts Payable | $39M | $24M | $30M | $25M | $26M | $43M | $38M | $59M | $29M | $26M | · | $26M | $26M | $33M | · | $31M | |
| Current Liabilities | $362M | $371M | $406M | $374M | $336M | $399M | $404M | $394M | $346M | $373M | · | $377M | $340M | $328M | · | $302M | |
| Capital Leases | $166M | $170M | $173M | $176M | $180M | $187M | $191M | $194M | $198M | $201M | · | $191M | $195M | $187M | · | $160M | |
| Other Non-current Liabilities | $123M | $117M | $104M | $113M | $129M | $120M | $109M | $96M | $110M | $101M | · | $62M | $73M | $67M | · | $2M | |
| Total Liabilities | $650M | $658M | $683M | $663M | $645M | $706M | $703M | $685M | $653M | $676M | · | $629M | $615M | $588M | · | $470M | |
| Common Stock | $249.0K | $254.0K | $262.0K | $268.0K | $270.0K | $275.0K | $282.0K | $286.0K | $285.0K | $295.0K | · | $311.0K | $320.0K | $325.0K | · | $323.0K | |
| Paid-in Capital | $2.11B | $2.15B | $2.23B | $2.26B | $2.25B | $2.29B | $2.34B | $2.36B | $2.32B | $2.39B | · | $2.49B | $2.53B | $2.56B | · | $2.51B | |
| Retained Earnings | $-263M | $-216M | $-77M | $-106M | $-220M | $-163M | $-99M | $-90M | $-200M | $-259M | · | $-126M | $11M | $6M | · | $-4M | |
| AOCI | $-2M | $-415.0K | $3M | $4M | $1M | $2M | $-1M | $4M | $-5M | $-5M | · | $-14M | $-14M | $-9M | · | $-18M | |
| Stockholders' Equity | $1.84B | $1.94B | $2.16B | $2.16B | $2.03B | $2.13B | $2.24B | $2.28B | $2.12B | $2.13B | $2.26B | $2.35B | $2.53B | $2.56B | $2.49B | $2.49B | |
| Liabilities + Equity | $2.49B | $2.59B | $2.84B | $2.82B | $2.68B | $2.84B | $2.95B | $2.96B | $2.77B | $2.80B | · | $2.98B | $3.14B | $3.14B | · | $2.96B | |
| Shares Outstanding | 248,885,000 | 253,701,000 | 262,483,000 | 268,098,000 | 270,132,000 | 275,033,000 | 281,732,000 | 285,780,000 | 285,222,000 | 295,032,000 | 302,793,000 | 310,970,000 | 320,253,000 | 324,985,000 | 323,951,000 | 322,541,000 |
नकदी प्रवाह
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2024 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7M | $7M | $8M | $7M | $7M | $7M | $10M | $7M | $7M | $6M | $7M | $6M | $6M | $7M | $6M | $6M | |
| Stock-based Comp | $33M | $29M | $45M | $31M | $36M | $26M | $12M | $23M | $25M | $19M | $24M | $40M | $25M | $17M | $26M | $37M | |
| Restructuring | · | · | $-13M | $20M | $0 | $0 | $34M | $96.0K | $475.0K | $33M | · | $0 | $0 | $0 | · | · | |
| Other Non-cash | · | $5M | · | · | · | $19M | · | · | · | $6M | · | · | · | $21M | · | · | |
| Operating Cash Flow | $308M | $252M | $425M | $290M | $49M | $211M | $377M | $271M | $120M | $69M | $11M | $117M | $121M | $84M | $74M | $110M | |
| CapEx | $7M | $2M | $-16M | $1M | $3M | $3M | $1M | $8M | $7M | $10M | $13M | $9M | $6M | $12M | $10M | $43.0K | |
| Investing Cash Flow | $91M | $-51M | $374M | $25M | $248M | $50M | $-28M | $-217M | $82M | $112M | $62M | $35M | $-74M | $-50M | $-246M | $-69M | |
| Stock Repurchased | $323M | $430M | $486M | $104M | $302M | $284M | $311M | $12M | $264M | $185M | $209M | $217M | $124M | $0 | $0 | $0 | |
| Net Stock Activity | · | $-430M | · | · | · | $-284M | · | · | · | $-185M | · | · | · | · | · | · | |
| Financing Cash Flow | $-344M | $-457M | $-529M | $-104M | $-316M | $-295M | $-289M | $6M | $-262M | $-184M | $-206M | $-220M | $-125M | $5M | $-2M | $-2M | |
| Net Change in Cash | $55M | $-256M | $270M | $212M | $-19M | $-34M | $60M | $60M | $-61M | $-3M | $-134M | $-68M | $-78M | $39M | $-174M | $39M | |
| Free Cash Flow | · | $250M | · | · | · | $208M | · | · | · | $59M | · | · | · | $72M | · | · |
लाभप्रदता
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2024 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 39.5% | 41.1% | · | 39.6% | 37.6% | 33.6% | · | 25.2% | 43.3% | 6.9% | · | -3.7% | 16.6% | 7.0% | · | 20.1% | |
| Net Margin | 33.7% | 34.5% | · | 32.4% | 32.5% | 28.7% | · | 21.9% | 35.5% | 8.8% | · | 0.22% | 17.3% | 9.8% | · | 17.8% | |
| EBITDA Margin | 39.5% | 42.3% | · | 39.6% | 37.6% | 35.0% | · | 25.2% | 43.3% | 8.4% | · | -3.7% | 16.6% | 8.7% | · | 20.1% | |
| ROA | 8.2% | 7.8% | · | 6.7% | 6.8% | 5.7% | · | 4.0% | 7.6% | 1.2% | · | 0.04% | 2.7% | 1.4% | · | 2.7% | |
| ROE | 10.9% | 10.3% | · | 8.7% | 8.9% | 7.5% | · | 5.1% | 9.7% | 1.6% | · | 0.04% | 3.3% | 1.7% | · | 3.2% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2024 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.3 | · | 3.8 | 3.5 | 3.5 | · | 3.9 | 4.3 | 3.5 | · | 3.8 | 4.7 | 5.0 | · | 6.1 | |
| Quick Ratio | 3.2 | 3.0 | · | 3.5 | 3.2 | 3.3 | · | 3.7 | 4.0 | 3.2 | · | 3.6 | 4.4 | 4.7 | · | 5.8 |
दक्षता
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2024 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.8 | · | 0.8 | 0.7 | 0.8 | · | 0.7 | 0.6 | 0.5 | · | 0.6 | |
| Receivables Turnover | 2.0 | 2.0 | · | 2.1 | 1.6 | 2.1 | · | 2.1 | 2.0 | 1.8 | · | 2.0 | 2.0 | 1.9 | · | 2.1 |
प्रति शेयर
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2024 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.41 | $7.63 | · | $8.06 | $7.53 | $7.75 | · | $7.96 | $7.43 | $7.21 | · | $7.55 | $7.89 | $7.86 | · | $7.72 | |
| Revenue / Share | $2.42 | $2.28 | · | $2.15 | $2.00 | $1.93 | · | $1.85 | $2.17 | $1.39 | · | $1.48 | $1.44 | $1.25 | · | $1.27 | |
| Cash Flow / Share | · | $0.94 | · | · | · | $0.73 | · | · | · | $0.23 | · | · | · | $0.26 | · | · | |
| Cash / Share | $1.13 | $0.89 | · | $1.40 | $0.61 | $0.67 | · | $0.90 | $0.70 | $0.88 | · | $1.28 | $1.45 | $1.66 | · | $2.09 | |
| EPS (TTM) | $3.79 | $3.62 | · | $3.28 | $2.99 | $3.11 | · | $1.57 | $1.17 | $0.65 | · | $0.28 | $0.51 | $0.48 | · | $0.93 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2024 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.56B | $2.50B | · | $2.54B | $2.48B | $2.55B | · | $2.08B | $2.01B | $1.85B | · | $1.77B | $1.71B | $1.66B | · | $1.74B | |
| Net Income TTM | $1.02B | $990M | · | $937M | $861M | $903M | · | $467M | $350M | $205M | · | $92M | $164M | $154M | · | $297M | |
| Market Cap | $13.90B | $11.13B | · | $10.75B | $12.47B | $9.51B | · | $7.42B | $6.41B | $7.00B | · | $6.79B | $6.12B | $6.31B | · | $5.06B | |
| P/E | 14.7 | 12.1 | · | 12.2 | 15.4 | 11.1 | · | 16.5 | 19.2 | 36.5 | · | 78.0 | 37.5 | 40.4 | · | 16.9 | |
| P/S | 5.4 | 4.5 | · | 4.2 | 5.0 | 3.7 | · | 3.6 | 3.2 | 3.8 | · | 3.8 | 3.6 | 3.8 | · | 2.9 | |
| P/B | 7.5 | 5.8 | · | 5.0 | 6.1 | 4.5 | · | 3.3 | 3.0 | 3.3 | · | 2.9 | 2.4 | 2.5 | · | 2.0 | |
| P / Tangible Book | 7.8 | 5.9 | · | 5.1 | 6.3 | 4.6 | · | 3.4 | 3.1 | 3.4 | · | 3.0 | 2.5 | 2.5 | · | 2.1 | |
| P / Cash Flow | · | 44.2 | · | · | · | 45.0 | · | · | · | 101.7 | · | · | · | 74.7 | · | · | |
| Earnings Yield | 6.8% | 8.2% | · | 8.2% | 6.5% | 9.0% | · | 6.0% | 5.2% | 2.7% | · | 1.3% | 2.7% | 2.5% | · | 5.9% |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2026-01-02 | 2025-01-03 | 2023-12-29 | 2022-12-30 | 2021-12-31 |
|---|---|---|---|---|---|
| राजस्व | $2.32B | $2.17B | $1.83B | $1.61B | $1.43B |
| परिचालन मार्जिन % | 37.6% | 27.9% | 9.3% | 12.5% | 20.0% |
| शुद्ध आय | $783M | $521M | $208M | $182M | $231M |
| तनुकरणित EPS | $2.78 | $1.76 | $0.65 | $0.56 | $0.72 |
| मेट्रिक | 2026-01-02 | 2025-01-03 | 2023-12-29 | 2022-12-30 | 2021-12-31 |
|---|---|---|---|---|---|
| वर्तमान अनुपात | 3.6 | 3.6 | 3.3 | 5.0 | 5.4 |
| त्वरित अनुपात | 3.3 | 3.4 | 3.1 | 4.7 | 5.2 |
| मेट्रिक | 2026-01-02 | 2025-01-03 | 2023-12-29 | 2022-12-30 | 2021-12-31 |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $876M | $672M | $293M | $335M | $337M |
संस्थागत मालिक (13F) 806 फाइलर्स · $14.5B कुल · तिथि अनुसार 30 सितमबर 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
धारक
806
धारित मूल्य
$14.5B
नई स्थितियाँ
129
बाहर निकली पोजीशन
62
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 129 (+13 पिछली तिमाही की तुलना में) | 62 (-11 पिछली तिमाही की तुलना में) | 252 (+12 पिछली तिमाही की तुलना में) | 282 (+16 पिछली तिमाही की तुलना में) | +15.7M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| BlackRock, Inc. | $1581991274 | 29075377 | 10.92% | शेयर |
| VANGUARD GROUP INC | $1117246380 | 25490449 | 7.71% | शेयर |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $732794424 | 13468010 | 5.06% | शेयर |
| RENAISSANCE TECHNOLOGIES LLC | $730617099 | 13427993 | 5.04% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $655266268 | 12043122 | 4.52% | शेयर |
| AQR CAPITAL MANAGEMENT LLC | $598600120 | 11023943 | 4.13% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $595843747 | 10950997 | 4.11% | शेयर |
| STATE STREET CORP | $542471563 | 9970071 | 3.74% | शेयर |
| FULLER & THALER ASSET MANAGEMENT, INC. | $485848030 | 8929389 | 3.35% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $416318915 | 7650316 | 2.87% | शेयर |
| D. E. Shaw & Co., Inc. | $302070554 | 5551747 | 2.08% | शेयर |
| MORGAN STANLEY | $245916111 | 4519684 | 1.70% | शेयर |
| Invesco Ltd. | $244610874 | 4495697 | 1.69% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $240852968 | 4426620 | 1.66% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $237550034 | 4365926 | 1.64% | शेयर |
| TWO SIGMA INVESTMENTS, LP | $229058537 | 4209861 | 1.58% | शेयर |
| ASSETMARK, INC | $186834364 | 3433824 | 1.29% | शेयर |
| Nuveen, LLC | $178300700 | 3276984 | 1.23% | शेयर |
| UBS Group AG | $172364895 | 3167890 | 1.19% | शेयर |
| Stephens Investment Management Group LLC | $147451698 | 2710011 | 1.02% | शेयर |
| GOLDMAN SACHS GROUP INC | $146389506 | 2690489 | 1.01% | शेयर |
| NORGES BANK | $146301199 | 2688866 | 1.01% | शेयर |
| FIRST TRUST ADVISORS LP | $138383701 | 2543353 | 0.96% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $123065409 | 2261816 | 0.85% | शेयर |
| BANK OF AMERICA CORP /DE/ | $116948690 | 2149397 | 0.81% | शेयर |
| NORTHERN TRUST CORP | $115680775 | 2126094 | 0.80% | शेयर |
| Caisse de depot et placement du Quebec | $113950809 | 2094299 | 0.79% | शेयर |
| Allspring Global Investments Holdings, LLC | $107837495 | 1998471 | 0.74% | शेयर |
| Bank of New York Mellon Corp | $107803106 | 1981311 | 0.74% | शेयर |
| AMERICAN CENTURY COMPANIES INC | $97484439 | 1791664 | 0.67% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $86563209 | 1590943 | 0.60% | शेयर |
| Caligan Partners LP | $84512985 | 1553262 | 0.58% | शेयर |
| JANE STREET GROUP, LLC | $76306652 | 1402438 | 0.53% | शेयर |
| JPMORGAN CHASE & CO | $71082192 | 1298907 | 0.49% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $66309793 | 1218706 | 0.46% | शेयर |
| SEI INVESTMENTS CO | $63480220 | 1166715 | 0.44% | शेयर |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $63086055 | 1159457 | 0.44% | शेयर |
| FMR LLC | $62457967 | 1147913 | 0.43% | शेयर |
| FRANKLIN RESOURCES INC | $60000791 | 1102753 | 0.41% | शेयर |
| AMERIPRISE FINANCIAL INC | $56803835 | 1043869 | 0.39% | शेयर |
| Robeco Institutional Asset Management B.V. | $56032453 | 1029819 | 0.39% | शेयर |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $55414608 | 1292017 | 0.38% | शेयर |
| ENVESTNET ASSET MANAGEMENT INC | $51671488 | 949669 | 0.36% | शेयर |
| RAYMOND JAMES FINANCIAL INC | $51230878 | 941571 | 0.35% | शेयर |
| Gotham Asset Management, LLC | $48569794 | 892663 | 0.34% | शेयर |
| Swedbank AB | $45801141 | 841778 | 0.32% | शेयर |
| MARSHALL WACE, LLP | $45242242 | 831506 | 0.31% | शेयर |
| Retirement Systems of Alabama | $44107739 | 810655 | 0.30% | शेयर |
| BOOTHBAY FUND MANAGEMENT, LLC | $43750809 | 804095 | 0.30% | शेयर |
| Capital Impact Advisors, LLC | $41061268 | 754664 | 0.28% | शेयर |
कार्यकर्ता और 5%+ मालिक 4 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Farallon Capital Management, L.L.C., Farallon Capital Partners, L.P., Farallon Capital Institutional Partners, L.P., Farallon Capital Institutional Partners II, L.P., Farallon Capital Institutional Partners III, L.P., Four Crossings Institutional Partners V, L.P., Farallon Capital Offshore Investors II, L.P., Farallon Capital (AM) Investors, L.P., Farallon Capital F5 Master I, L.P., Farallon Healthcare Partners Master, L.P., Farallon Partners, L.L.C., Farallon Institutional (GP) V, L.L.C., Farallon F5 (GP), L.L.C., Farallon Healthcare Partners (GP), L.L.C., Dapice Joshua J., Dreyfuss, Philip D., Dunn Hannah E., Gehani, Varun N., Giauque, Nicolas, Husen, Avner A., Kim, David T., Linn, Michael G., Luo Patrick (Cheng), Roberts, Jr., Thomas G., Saito Edric C., Short Daniel S., Spokes, Andrew J. M., Warren, John R., Wehrly, Mark C. | 14 अगस्त 2026 | 5.60% | संशोधन | · | SEC |
| Farallon Capital Partners, L.P., Farallon Capital Institutional Partners, L.P., Farallon Capital Institutional Partners II, L.P., Farallon Capital Institutional Partners III, L.P., Four Crossings Institutional Partners V, L.P., Farallon Capital Offshore Investors II, L.P., Farallon Capital (AM) Investors, L.P., Farallon Capital F5 Master I, L.P., Farallon Healthcare Partners Master, L.P., Farallon Partners, L.L.C., Farallon Institutional (GP) V, L.L.C., Farallon F5 (GP), L.L.C., Farallon Healthcare Partners (GP), L.L.C., Dapice Joshua J., Dreyfuss, Philip D., Dunn Hannah E., Fried, Richard B, Gehani, Varun N., Giauque, Nicolas, Husen, Avner A., Kim, David T., Linn, Michael G., Luo Patrick (Cheng), Patel, Rajiv A., Roberts, Jr., Thomas G., Saito Edric C., Seybold, William, Short Daniel S., Spokes, Andrew J. M., Warren, John R., Wehrly, Mark C. ×8 फाइलिंग | 5 जनवरी 2026 | 5.90% | संशोधन | · | SEC |
| Caligan Partners LP, David Johnson ×3 फाइलिंग | 2 जून 2023 | · | प्रारंभिक फाइलिंग | · | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 29 नवमबर 2001 | · | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
कंपनी के अंदरूनी सूत्र 43 इनसाइडर्स · 22 अधिकारी · 10 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Michael Morrissey | President and CEO | 18 मई 2026 G | 2004327 | 0 | 0 | $0 |
| Christopher J. Senner | EVP and CFO | 18 मई 2026 S | 952317 | 0 | 3 | $-4556048 |
| Deborah Burke | SVP & Chief Financial Officer | 15 नवमबर 2014 M | 18156 | 0 | 0 | $0 |
| Frank Karbe | EVP and CFO | 15 फ़रवरी 2014 M | 93990 | 0 | 0 | $0 |
| Kristine M Ball | Controller & Interim CFO | 10 दिसमबर 2003 A | 4913 | 0 | 0 | $0 |
| Patrick J. Haley | EVP, Commercial | 20 मई 2026 S | 357638 | 0 | 7 | $-7597268 |
| Brenda Hefti | SVP and General Counsel | 18 मई 2026 S | 106762 | 0 | 2 | $-1154264 |
| Amy C. Peterson | EVP Prod Dev & Med Aff & CMO | 16 मई 2025 M | 465393 | 0 | 0 | $0 |
| Jeffrey Hessekiel | EVP & General Counsel | 15 मई 2025 S | 693396 | 0 | 0 | $0 |
| Vicki L Goodman | EVP, Prod Dev & Med Aff &CMO | 3 अप्रैल 2023 A | 307654 | 0 | 0 | $0 |
| Peter Lamb | EVP, Scientific Strategy & CSO | 15 दिसमबर 2022 M | 410958 | 0 | 0 | $0 |
| Gisela Schwab | Pres, Prod Dev & Med Aff & CMO | 26 जुलाई 2021 M | 689078 | 0 | 0 | $0 |
| Pamela A Simonton | EVP and General Counsel | 15 नवमबर 2013 M | 17139 | 0 | 0 | $0 |
| Lupe M Rivera | EVP, Operations | 15 अगस्त 2011 M | 19219 | 0 | 0 | $0 |
| Frances K Heller | EVP, Business Development | 15 मई 2011 M | 17125 | 0 | 0 | $0 |
| Ian D Malcolm | VP, STRATEGIC MARKETING | 8 दिसमबर 2006 A | · | 0 | 0 | $0 |
| Christoph Pereira | VP, Legal Affairs & Secretary | 8 दिसमबर 2006 A | · | 0 | 0 | $0 |
| Jeffrey Latts | Executive VP, Development | 8 दिसमबर 2006 A | · | 0 | 0 | $0 |
| Gregory Plowman | Sr VP, CSO | 13 दिसमबर 2004 A | · | 0 | 0 | $0 |
| Steven P James | Sr VP, Commercial Ops | 10 दिसमबर 2003 A | · | 0 | 0 | $0 |
| Jane M Green | VP, Corp Communications | 10 दिसमबर 2003 A | · | 0 | 0 | $0 |
| Geoffrey M Duyk | Pres R&D & CSO | 4 नवमबर 2003 S | 941355 | 0 | 0 | $0 |
| Alan M Garber | निदेशक | 21 मार्च 2024 M | 35703 | 0 | 0 | $0 |
| Jacqueline Wright | निदेशक | 1 जून 2023 A | 51756 | 0 | 0 | $0 |
| Carl B Feldbaum | निदेशक | 9 फ़रवरी 2023 M | 18701 | 0 | 0 | $0 |
| Lance Willsey | निदेशक | 26 मई 2022 A | 424415 | 0 | 0 | $0 |
| Vincent T Marchesi | निदेशक | 26 मई 2022 A | 93989 | 0 | 0 | $0 |
| Charles Cohen | निदेशक | 6 जुलाई 2021 M | 261375 | 0 | 0 | $0 |
| George A Scangos | निदेशक | 18 मई 2020 S | 714717 | 0 | 0 | $0 |
| FORMELA JEAN FRANCOIS | निदेशक | 7 सितमबर 2005 S | 584519 | 0 | 0 | $0 |
| Mary C Beckerle | · | 10 अगस्त 2026 S | 16079 | 0 | 4 | $-1932572 |
| Sue Gail Eckhardt | · | 1 जून 2026 S | 16079 | 0 | 2 | $-660828 |
| Jack L Wyszomierski | · | 1 जून 2026 S | 284384 | 0 | 2 | $-4580661 |
| Tomas J. Heyman | · | 27 मई 2026 A | 50649 | 0 | 0 | $0 |
| Bob Oliver | · | 27 मई 2026 A | 29487 | 0 | 2 | $-1325340 |
| Julie Smith | · | 27 मई 2026 A | 28957 | 0 | 3 | $-4687346 |
| Maria C Freire | · | 27 मई 2026 A | 109186 | 0 | 1 | $-949164 |
| Stelios Papadopoulos | · | 27 मई 2026 A | 1197595 | 0 | 1 | $-4355000 |
| George Poste | · | 27 मई 2026 A | 127199 | 0 | 1 | $-2742600 |
| Dana Aftab | · | 26 मई 2026 S | 594741 | 0 | 4 | $-7701255 |
| Frank Mccormick | · | 6 दिसमबर 2013 A | · | 0 | 0 | $0 |
| Scott J. Garland | · | 18 सितमबर 2013 A | · | 0 | 0 | $0 |
| Jason S Fisherman | · | 8 सितमबर 2005 S | 7881 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 105 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| SAWG · ETF Series Solutions | 3.56% | 1934 NS | 31 जुलाई 2026 | N-PORT |
| IDNA · iShares Trust | 3.37% | 150179 SH | 11 सितमबर 2026 | दैनिक |
| XMHQ · Invesco Exchange-Traded Fund Trust | 3.37% | 3087866 SH | 1 अक्टूबर 2026 | दैनिक |
| PBE · Invesco Exchange-Traded Fund Trust | 2.85% | 206883 SH | 1 अक्टूबर 2026 | दैनिक |
| MCOW · Pacer Funds Trust | 2.67% | 535 NS | 31 जुलाई 2026 | N-PORT |
| AZTD · Tidal Trust I | 2.27% | 16241 NS | 31 जुलाई 2026 | N-PORT |
| GRPM · Invesco Exchange-Traded Fund Trust | 2.10% | 176843 SH | 1 अक्टूबर 2026 | दैनिक |
| LYLD · Cambria ETF Trust | 1.84% | 2519 NS | 31 जुलाई 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 1.74% | 344438 NS | 31 जुलाई 2026 | N-PORT |
| BUL · Pacer Funds Trust | 1.71% | 42248 NS | 31 जुलाई 2026 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 1.63% | 1243 NS | 31 जुलाई 2026 | N-PORT |
| JMID · Janus Detroit Street Trust | 1.62% | 7222 NS | 31 जुलाई 2026 | N-PORT |
| RFG · Invesco Exchange-Traded Fund Trust | 1.48% | 84215 SH | 1 अक्टूबर 2026 | दैनिक |
| PTH · Invesco Exchange-Traded Fund Trust | 1.38% | 86967 SH | 1 अक्टूबर 2026 | दैनिक |
| ABFL · Abacus FCF ETF Trust | 1.38% | 136571 NS | 31 जुलाई 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1.37% | 25544 NS | 31 जुलाई 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1.32% | 261689 NS | 31 जुलाई 2026 | N-PORT |
| VLLU · Harbor ETF Trust | 1.18% | 1028 NS | 31 जुलाई 2026 | N-PORT |
| IBB · iShares Trust | 1.04% | 1861562 SH | 11 सितमबर 2026 | दैनिक |
| COWG · Pacer Funds Trust | 0.97% | 406060 NS | 31 जुलाई 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.95% | 17520 SH | 1 अक्टूबर 2026 | दैनिक |
| VAMO · Cambria ETF Trust | 0.90% | 18388 NS | 31 जुलाई 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0.89% | 614023 NS | 31 जुलाई 2026 | N-PORT |
| SMDX · Tidal Trust III | 0.88% | 21573 NS | 31 जुलाई 2026 | N-PORT |
| FLRG · FIDELITY COVINGTON TRUST | 0.82% | 45034 NS | 31 जुलाई 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0.72% | 2087 NS | 31 जुलाई 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.72% | 248016 SH | 19 अगस्त 2026 | दैनिक |
| LABU · Direxion Shares ETF Trust | 0.69% | 64176 NS | 31 जुलाई 2026 | N-PORT |
| PDP · Invesco Exchange-Traded Fund Trust | 0.64% | 162471 SH | 1 अक्टूबर 2026 | दैनिक |
| HQGO · Lattice Strategies Trust | 0.53% | 4942 NS | 31 जुलाई 2026 | N-PORT |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0.53% | 64827 NS | 31 जुलाई 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.51% | 144430 SH | 1 अक्टूबर 2026 | दैनिक |
| VFQY · VANGUARD WELLINGTON FUND | 0.49% | 42746 SH | 19 अगस्त 2026 | दैनिक |
| IQSM · New York Life Investments ETF Trust | 0.47% | 29280 NS | 31 जुलाई 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.46% | 50608 NS | 31 जुलाई 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0.45% | 31352 SH | 1 अक्टूबर 2026 | दैनिक |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.40% | 35114 NS | 31 जुलाई 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.39% | 33972 NS | 31 जुलाई 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0.38% | 50612 NS | 31 जुलाई 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0.37% | 27665 NS | 31 जुलाई 2026 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.37% | 406142 SH | 19 अगस्त 2026 | दैनिक |
| VBK · VANGUARD INDEX FUNDS | 0.36% | 3162797 SH | 19 अगस्त 2026 | दैनिक |
| BKMC · BNY Mellon ETF Trust | 0.31% | 38444 NS | 31 जुलाई 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.29% | 3691 NS | 31 जुलाई 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.28% | 131971 NS | 31 जुलाई 2026 | N-PORT |
| TECB · iShares Trust | 0.28% | 24022 SH | 11 सितमबर 2026 | दैनिक |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.26% | 100220 NS | 31 जुलाई 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0.25% | 31728 SH | 19 अगस्त 2026 | दैनिक |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0.24% | 111481 NS | 31 जुलाई 2026 | N-PORT |
| IYH · iShares Trust | 0.23% | 146188 SH | 11 सितमबर 2026 | दैनिक |
| ISCG · iShares Trust | 0.22% | 36896 SH | 11 सितमबर 2026 | दैनिक |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.22% | 56792 NS | 31 जुलाई 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.21% | 599685 NS | 31 जुलाई 2026 | N-PORT |
| SMMD · iShares Trust | 0.20% | 132873 SH | 11 सितमबर 2026 | दैनिक |
| PWS · Pacer Funds Trust | 0.19% | 877 NS | 31 जुलाई 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.19% | 706287 SH | 19 अगस्त 2026 | दैनिक |
| FHLC · FIDELITY COVINGTON TRUST | 0.18% | 111648 NS | 31 जुलाई 2026 | N-PORT |
| ESML · iShares Trust | 0.18% | 85358 SH | 11 सितमबर 2026 | दैनिक |
| VB · VANGUARD INDEX FUNDS | 0.16% | 5476589 SH | 19 अगस्त 2026 | दैनिक |
| VXF · VANGUARD INDEX FUNDS | 0.15% | 2881105 SH | 19 अगस्त 2026 | दैनिक |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.14% | 15194 NS | 31 जुलाई 2026 | N-PORT |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0.13% | 200502 NS | 31 जुलाई 2026 | N-PORT |
| WSML · iShares Trust | 0.13% | 14622 SH | 11 सितमबर 2026 | दैनिक |
| VFVA · VANGUARD WELLINGTON FUND | 0.11% | 17726 SH | 19 अगस्त 2026 | दैनिक |
| IWP · iShares Trust | 0.11% | 358092 SH | 11 सितमबर 2026 | दैनिक |
| LRGF · iShares Trust | 0.11% | 68576 SH | 11 सितमबर 2026 | दैनिक |
| HDUS · Lattice Strategies Trust | 0.11% | 4054 NS | 31 जुलाई 2026 | N-PORT |
| IWR · iShares Trust | 0.11% | 1021935 SH | 11 सितमबर 2026 | दैनिक |
| IWS · iShares Trust | 0.11% | 278528 SH | 11 सितमबर 2026 | दैनिक |
| RWK · Invesco Exchange-Traded Fund Trust … | 0.10% | 21854 SH | 1 अक्टूबर 2026 | दैनिक |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 13139 SH | 1 अक्टूबर 2026 | दैनिक |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.08% | 65943 SH | 1 अक्टूबर 2026 | दैनिक |
| DFUV · Dimensional ETF Trust | 0.07% | 214466 NS | 31 जुलाई 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.06% | 5961 NS | 31 जुलाई 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.06% | 512586 NS | 31 जुलाई 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.04% | 28149 NS | 31 जुलाई 2026 | N-PORT |
| IUSG · iShares Trust | 0.04% | 221278 SH | 11 सितमबर 2026 | दैनिक |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.04% | 6194 SH | 30 सितमबर 2026 | दैनिक |
| PRF · Invesco Exchange-Traded Fund Trust | 0.03% | 53389 SH | 1 अक्टूबर 2026 | दैनिक |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 112032 SH | 19 अगस्त 2026 | दैनिक |
| IWD · iShares Trust | 0.03% | 412002 SH | 11 सितमबर 2026 | दैनिक |
| TILT · FlexShares Trust | 0.03% | 11534 NS | 31 जुलाई 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0.03% | 190630 SH | 11 सितमबर 2026 | दैनिक |
| REVS · Columbia ETF Trust I | 0.03% | 1649 NS | 31 जुलाई 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.03% | 58894 NS | 31 जुलाई 2026 | N-PORT |
| IYY · iShares Trust | 0.02% | 10758 SH | 11 सितमबर 2026 | दैनिक |
| IWB · iShares Trust | 0.02% | 172055 SH | 11 सितमबर 2026 | दैनिक |
| VTI · VANGUARD INDEX FUNDS | 0.02% | 7584437 SH | 19 अगस्त 2026 | दैनिक |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.02% | 41043 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.02% | 21010 SH | 19 अगस्त 2026 | दैनिक |
| ESGV · VANGUARD WORLD FUND | 0.02% | 56278 SH | 19 अगस्त 2026 | दैनिक |
| ITOT · iShares Trust | 0.02% | 328550 SH | 11 सितमबर 2026 | दैनिक |
| IWV · iShares Trust | 0.02% | 68474 SH | 11 सितमबर 2026 | दैनिक |
| DFUS · Dimensional ETF Trust | 0.02% | 76305 NS | 31 जुलाई 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0.02% | 20836 NS | 31 जुलाई 2026 | N-PORT |
| IWF · iShares Trust | 0.01% | 238944 SH | 11 सितमबर 2026 | दैनिक |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 214636 SH | 19 अगस्त 2026 | दैनिक |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 100382 SH | 19 अगस्त 2026 | दैनिक |
| IJH · iShares Trust | · | 8819629 SH | 11 सितमबर 2026 | दैनिक |
| IJK · iShares Trust | · | 1457702 SH | 11 सितमबर 2026 | दैनिक |
| XJH · iShares Trust | · | 34337 SH | 8 सितमबर 2026 | दैनिक |
| ISCB · iShares Trust | · | 10294 SH | 11 सितमबर 2026 | दैनिक |
| ISCV · iShares Trust | · | 24871 SH | 11 सितमबर 2026 | दैनिक |
| SMLF · iShares Trust | · | 251598 SH | 11 सितमबर 2026 | दैनिक |
| SMMV · iShares Trust | · | 21241 SH | 19 अगस्त 2026 | दैनिक |
EXEL विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
रेटिंग · 27 विश्लेषक
खरीदें
मध्यिका लक्ष्य
$53.00
-9.2%
4 14.8%
मजबूत खरीद
8 29.6%
खरीदें
14 51.9%
होल्ड
1 3.7%
बेचें
0 0.0%
मजबूत बिक्री
12-महीने का मूल्य लक्ष्य
15 विश्लेषक · 2026-10-01माध्य लक्ष्य $53.93 -7.6%
अभी
वर्तमान मूल्य $58.39
निम्न$41.00
माध्य$53.93
उच्च$66.00
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | · |
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | · |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | · |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | · |
| SMMT | $13.56B | -12.1 | · | · | -235.1% | · |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | · |
| TWST | $1.71B | -21.6 | 20.3% | -20.6% | -17.0% | · |
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | · |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | · |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
ट्रेडिंग सिग्नल प्रवेश मूल्य और जोखिम/इनाम अनुपात के साथ हालिया खरीद/बिक्री संकेत
BLUECHIP_DIP
स्टॉप आउट
जोखिम 1
पुरस्कार 1.67
प्रवेश
$53.65
R:R 1.67
BLUECHIP_DIP
समाप्त
जोखिम 1
पुरस्कार 4.80
प्रवेश
$41.37
R:R 4.80
BOUNCE_UP
समाप्त
जोखिम 1
पुरस्कार 2.00
प्रवेश
$42.17
R:R 2.00
BOUNCE_UP
लक्ष्य हिट
जोखिम 1
पुरस्कार 1.50
प्रवेश
$34.23
R:R 1.50
अभी कोई खुला सिग्नल नहीं — कोई कार्ड भरा नहीं है, और यह ईमानदार है।
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
स्रोत: SEC 10-Q अग 5, 2026 को फाइल किया गया